Cargando…
Clinical Study of Metabolic Parameters, Leptin and the SGLT2 Inhibitor Empagliflozin among Patients with Obesity and Type 2 Diabetes
Obesity is a major public health problem worldwide, and it is associated with many diseases and abnormalities, most importantly, type 2 diabetes. The visceral adipose tissue produces an immense variety of adipokines. Leptin is the first identified adipokine which plays a crucial role in the regulati...
Autores principales: | Szekeres, Zsolt, Sandor, Barbara, Bognar, Zita, Ramadan, Fadi H. J., Palfi, Anita, Bodis, Beata, Toth, Kalman, Szabados, Eszter |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10002958/ https://www.ncbi.nlm.nih.gov/pubmed/36901837 http://dx.doi.org/10.3390/ijms24054405 |
Ejemplares similares
-
The Effects of SGLT2 Inhibitors on Lipid Metabolism
por: Szekeres, Zsolt, et al.
Publicado: (2021) -
Examination of Self-Esteem, Body Image, Eating Attitudes and Cardiorespiratory Performance in Adolescents
por: Petrovics, Peter, et al.
Publicado: (2021) -
Association between Obesity and Overweight and Cardiorespiratory and Muscle Performance in Adolescents
por: Petrovics, Peter, et al.
Publicado: (2020) -
Empagliflozin-Associated Pancreatitis: A Consideration for SGLT2 Inhibitors
por: Dziadkowiec, Karolina N., et al.
Publicado: (2021) -
Effects of Moderate Aerobic Exercise Training on Hemorheological and Laboratory Parameters in Ischemic Heart Disease Patients
por: Sandor, Barbara, et al.
Publicado: (2014)